March 22-23, 2021
( Webinar) Vienna, Austria
We’ve invited the top most influential speakers from around the world to give inspirational talks and lead practical workshops.
PHARMA 2021 welcomes attendees, presenters, and exhibitors from all over the world . We are delighted to invite you all to attend and register for the “2nd Global Conference on Pharma and Pharmaceutical Sciences ” which is going to be held during Febraury 26-27,2021, Webinar.
PHARMA 2021 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment in Pharma, Pharmaceutical science , which provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come to join us at our event and make it successful by your participation.
At PULSUS Group, it is our ideology to bring maximum exposure to our attendees, so we make sure the event is a blend which covers professionals such as Pharmaceutical Scientists, Veteran Researchers, Healthcare Professionals from academia & industry making the PHARMA 2021 conference a perfect platform.
The conference will be organized around the theme ‘Challenges And Opportunities in Advancing The Future Of Pharma”. Our goal is to deliver an outstanding program which covers the entire spectrum of research & innovations in Pharma, Pharmaceutical science, Biopharmaceutics and Radiopharmaceuticals share the cross-cultural experiences of various treatment procedures.
At Pharma 2021 meet your target audiences from around the world focused on learning about Pharma and Pharma regulations, licenses, approvals. This conference would be your single best opportunity to reach the largest assemblage of participants from the Pharma field.
2019 Highlights:
Motives to attend:
Get ahead of the competition: Gather fresh intuitions from key speakers to help make restored decisions on doing business in Pharma.
Meet & Connect with Senior Stakeholders from the global Pharma network
Content your way: Access a variety of technical and commercial tracks across the entire supply chain, or choose the one track that is most relevant to your business
Save months of research: Don’t spend eras reading whitepapers, come and hear from the decision makers themselves on the latest trends, challenges and opportunities at the forefront of the industry
A Unique Opportunity for Advertisers and Sponsors at this International event
Triumph of Awards, Certificates recognizes your commitment to your profession to encourage the nascent research.
Over 50+ organizations and international pavilions will be exhibiting at the PHARMA 2020 conference. Exhibitors will include equipment manufacturers and suppliers, systems providers, finance and investment firms, R&D companies, project developers, trade associations, and government agencies.
In addition to the products and services you will have access to valuable content, including Keynote Presentations, Product Demonstrations and Educational Sessions from today’s industry leaders.
The PHARMA 2021 has everything you need, all under one roof, saving you both time and money. It is the event you cannot afford to miss!
Target Audience:
For Researchers and Faculty Members:
For Universities, Associations & Societies:
For Students and Research Scholars:
For Business Delegates:
For Product Manufacturers:
Market Analysis
The pharmaceutical industry comprises of companies that are engaged in research, development, manufacture and distribution drugs for human or veterinary use. The primary function of the research-based pharmaceutical corporations is to create value by discovering and producing effective medicines, vaccines and services that improve patients’ well-being, and can be sold in markets at a profit. As well as increasing shareholder value, this contributes significantly to the quality and protection of life and helps make the world a better place. In the past 60 years, innovation and technology have driven huge improvements in global health.
The pharmaceutical industry is undergoing a tremendous deal of change. There are many pharmaceutical companies, who are providing the better products. The Pharma industry is one of the most sought after, and flourished industries. As the pharmaceutical drug manufacturers are one of the reasons for the economic well being of a nation. On the other hand, we can say that the Pharma industry is responsible for the economic development. That is the main reason for both research and development of newer and better products for various kinds of diseases.
Top Pharmacy companies around the Globe:
As a highly specialized production location for pharmaceutical products, Switzerland enjoys an excellent reputation the world over. The presence of highly qualified scientists and pharmaceutical talent from the world’s leading universities make a significant contribution towards developing new medicines. The framework conditions are also in place: the Swiss healthcare system supports the introduction of new medicines and, in doing so, offers companies access to a sophisticated test and sales market. In addition to Switzerland, international markets play a decisive role. Value added in the pharmaceutical industry has continued to increase over the last decade in Switzerland. Switzerland is by far the most important stock exchange for Life Sciences companies in Europe.
Market Analysis of Global Pharmaceutical Industries:
The global $1.12 trillion market in 2022, will rise at a faster clip during 2016-2020, then slow down a bit as major patent expiration take hold. It is expected that the global market declined by 1.0% in 2015, but will grow by 4.8% this year. Prescription sales excluding generics will rise 4.4% this year, and expected to reach $1.006 trillion in 2022. Generics sales will increase from $73 billion in 2015 to $115 billion in 2022, and constitute 10.2% of prescription sales at that point only 0.3 percentage points more than it is now.
The global market for drug discovery technologies and products was worth $38.4 billion in 2011. This figure is projected to reach $41.4 billion in 2012 and $79 billion in 2017, a five-year compound annual growth rate (CAGR) of 13.8%. There is a need to impede serious adverse effects caused by the drugs by enhancing drug targeting through research in pharmacology.The global revenue for single use technology reached $1.4 billion and $1.7 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.7% to nearly $3.0 billion for the period 2014-2019.
The fast-growing division of the pharmaceutical market includes generics and biologics. Biologics now account for over a third of all new drugs in clinical trials or awaiting FDA approval.15 U.S generic drug sales reached an estimated $70 billion, representing a quarter of the global market, due to a large number of drugs going off-patent and healthcare reforms favoring generics. Although generics make up only 22 percent of total prescription sales, its share of filled prescriptions has risen from 19 percent in 1984 to 88 percent in 2015. The research-based pharmaceutical industry is estimated to have spent nearly USD 149.8 billion globally on pharmaceutical R&D in 2015-16. Among all the industrial sectors, the research-based pharmaceutical industry has consistently invested the most in research and development, even in times of economic turmoil and monetary crisis.
According to the Quintiles IMS Institute predicts that the pharmaceutical market by 2021 will reach nearly USD 1,485 billion, by an increase of USD 350-380 billion from the USD 1,105 billion recorded in 2016. Global brand spending is forecast to increase to USD 815-832 billion in 2021. Global generic spending is expected to increase to USD 495-505 billion by 2021.
The United States share of global spending will increase from USD 461.7 billion in 2016 to USD 645-675 billion in 2021, while the European share of spending will grow from USD 151.8 billion to USD 170-200 billion. Meanwhile, pharmerging countries will spend nearly 315-345 USD billion in 2021 from 242.9 in 2016.
Major Pharma Associations around the Globe:
Glance at Market of Pharma:
These data describe the outcome of the patient as defined in U.S reporting regulations. Serious means that one or more of the following outcomes were documented in the report: death, hospitalization, life threatening. There is a need to impede serious adverse effects caused by the drugs by enhancing drug targeting through research in pharmacy.
Pharma Middle East 2018 provides the best zone to share and gain knowledge. It is going to be a 3-day event to ensure network for clinical excellences, research advancements, global knowledge on pharma, emerging technologies and can transform formulation and drug delivery, Innovative scientific techniques, new utilities of Pharmaceutical Sciences at one place.
Role of Pharma in World:
Pharma companies have always interacted with consumers. They have marketed directly to users, especially in the U.S., and they involve patients in clinical trials. They thus have some limited experience with consumer-facing business models.In this new era, pharma companies will have to become more proactive with large communities of patients and go beyond lip service in meeting the needs of a wide swath of consumers
The top 10 Countries that have earned highest revenue through Pharmaceutical Manufacturings in the year 2020:
Pharma Market Analysis
The top Pharmaceutical drugs that were manufactured and sold in the year 2016
The global market for Antifungal Drugs was valued at $13.1 billion in 2016. The market should reach $16.1 billion by 2021, growing at a compound annual growth rate (CAGR) of 4.2% from 2016 to 2021, Diabetes market should reach $155 billion by 2021 from $125 billion in 2016 at a compound annual growth rate (CAGR) of 4.4%, from 2016 to 2021, Generic drugs should reach $533 billion by 2021 from $352 billion in 2016 at a compound annual growth rate (CAGR) of 8.7%, from 2016 to 2021, Cardiovascular drugs market should reach $149.4 billion by 2022 from $141.1 billion in 2017 at a compound annual growth rate (CAGR) of 1.2%, from 2017 to 2022, Infertility drugs should reach $4.2 billion by 2022 from $3.4 billion in 2017 at a compound annual growth rate (CAGR) of 4.3%, from 2017 to 2022, Stem cellstotalled $7.4 billion in 2017 and is estimated to reach $14.8 billion by 2022, growing at a compound annual growth rate (CAGR) of 14.7% for the period of 2017-2022, Infectious disease treatments totalled $64.8 billion in 2017. The market should total $99 billion by 2022, growing at a compound annual growth rate (CAGR) of 8.9% from 2017 to 2022 and the market for Gastrointestinal disorder therapeutics and diagnostics reached $49.6 billion in 2015. This market is expected to grow from nearly $51.8 billion in 2016 to $63.8 billion in 2021 at a compound annual growth rate of 4.3% from 2016-2021.
The global market for Botanical and plant-derived drugs will grow from $29.4 billion in 2017 to around $39.6 billion by 2022 with a compound annual growth rate (CAGR) of 6.1% for the period of 2017-2022.
The top 10 Companies in the World with highest revenue in Pharmaceutical Industries:
Biggest Pharmaceutical Companies in the World:
